CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- 4 Shares withheld for taxes Chief Operating Officer gave up 29,289 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,752 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 47,120 shares (to pay taxes)
- 4 Open-market buy President and CEO bought 40,000 shares at $5.00 ($199,844)
- 4 Shares withheld for taxes Chief People Officer gave up 1,675 shares (to pay taxes)
- 4 Open-market buy Director bought 104,507 shares at an average $4.73 ($494,722)
- 4 Grant or award Chief Financial Officer acquired 4,994 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 32,810 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 23,697 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 23,697 shares (grant or award)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 418 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 21 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 29,634 shares (to pay taxes)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Shares withheld for taxes Chief Operating Officer gave up 1,085 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 962 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,559 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Strategy & Transformation gave up 958 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 4,435 shares (to pay taxes)
Page 3 of 65 · 1,293 filings